RT @TuvaRB: The retail price of #insulin may go as high as 10 times the production costs. Norway supports a global price reporting mechanism for insulin. “there clearly is a need for more transparency,» says @dagiulstein #NCDs @WHO https://t.co/xKP9OfttRy